NEW YORK (Reuters Health) – Among patients with atrial fibrillation undergoing mechanical valve replacement, performing a concomitant Maze procedure during surgery reduces the rate of subsequent thromboembolic events,…
NEW YORK (Reuters Health) – In general, adding pemetrexed to cisplatin therapy does not improve overall survival (OS) in patients with recurrent or metastatic head and neck cancer,…
NEW YORK (Reuters Health) – Occult Staphylococcus aureus bacteremia is a “rare but important” issue in adult emergency department patients, one that deserves closer attention, a team of…
NEW YORK (Reuters Health) – Cigarette smoking enhanced the effects of clopidogrel in a study of diabetics with coronary artery disease. Accordingly, smokers were less likely to experience…
NEW YORK (Reuters Health) – Real-world outcomes among patients with stable coronary disease favor percutaneous coronary intervention over routine medical care alone, according to data maintained by the…
NEW YORK (Reuters Health) – An investigational phosphodiesterase type 5 (PDE5) inhibitor, avanafil, is an effective and well tolerated treatment for erectile dysfunction (ED), according to the results…
NEW YORK (Reuters Health) – Results of a meta-analysis show that in preterm infants with respiratory distress syndrome, early use of nasal intermittent positive pressure ventilation (NIPPV) compared…
NEW YORK (Reuters Health) – Empiric therapy in extremely low birth weight (ELBW) infants with invasive Candida infections is associated with improved outcomes (less death and neurodevelopmental impairment),…
NEW YORK (Reuters Health) – An investigational formulation of azelastine and fluticasone (MP29-02) is more effective than either agent alone as intranasal therapy for moderate-to-severe seasonal allergic rhinitis…
NEW YORK (Reuters Health) – The investigational GLP-1 receptor antagonist lixisenatide significantly reduces postprandial glucose excursions and HbA1c in patients with type 2 diabetes who have not been…
